As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Bausch Health Companies Inc. The largest reported stake is Paulson & Co. Inc.'s, at 19.1%. 4 filings are on record since August 14, 2025 (Schedule 13D/A, August 14, 2025).
Sell to companies like Bausch Health Companies Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Nomura Holdings Inc · Sole voting: 0 · Shared voting: 15,708,085 · Sole dispositive: 0 · Shared dispositive: 15,708,085 · SCHEDULE 13G/A, 2025-11-14
- · Reporting person: Icahn Partners Master Fund LP · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 0 · SCHEDULE 13D/A, 2025-08-15
- · Holder: Paulson & Co. Inc. · Percent: 19.1% · Shares: 70,755,869 · SCHEDULE 13D/A
- · Reporting person: GoldenTree Asset Management LP · Sole voting: 0 · Shared voting: 34,254,889 · Sole dispositive: 0 · Shared dispositive: 34,254,889 · SCHEDULE 13G/A, 2025-08-14
Bausch Health Companies Inc. has 4 Schedule 13D or 13G filings on record since 2025-08-14. 2 holders' latest filing reports 5% or more of common shares, no par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Paulson & Co. Inc. | 19.1% | 70,755,869 | SCHEDULE 13D/A, 2025-08-14 | 2025-08-14 |
| 9.5% | 35,243,712 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 | |
| Nomura Holdings Inc | 4.2% | 15,708,085 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
| 0% | 0 | SCHEDULE 13D/A, 2025-08-15 | 2025-08-14 |
Holding shares or following this stake? See who's behind Bausch Health Companies Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Bausch Health Companies Inc. and the records around it.
Bausch Health Companies Inc. elsewhere on the record
Companies that share a holder
- GoldenTree Asset Management LP also filed stake reports on 4 other companies: QVC GROUP, INC. (Oct 2026), Keenova Therapeutics plc (Oct 2026), GoldenTree Opportunistic Credit Fund (Jun 2026)
- PAULSON & CO. INC. also filed stake reports on 5 other companies: Madrigal Pharmaceuticals, Inc. (May 2026), INTERNATIONAL TOWER HILL MINES LTD (Apr 2026), NOVAGOLD RESOURCES INC (Aug 2025)
- Icahn Partners Master Fund LP also filed stake reports on 8 other companies: Icahn Enterprises L.P. (Sep 2026), JETBLUE AIRWAYS CORP (Aug 2026), ENZON PHARMACEUTICALS, INC. (Mar 2026)
Watch Bausch Health Companies Inc.
Get an email when Bausch Health Companies Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Bausch Health Companies Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Bausch Health Companies Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Bausch Health Companies Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Paulson & Co. Inc. | 70,755,869 | 0 | 70,755,869 | 0 | SCHEDULE 13D/A, 2025-08-14 |
| GoldenTree Asset Management LP | 0 | 34,254,889 | 0 | 34,254,889 | SCHEDULE 13G/A, 2025-08-14 |
| GoldenTree Asset Management LLC | 0 | 34,254,889 | 0 | 34,254,889 | SCHEDULE 13G/A, 2025-08-14 |
| Steven A. Tananbaum | 988,823 | 34,254,889 | 988,823 | 34,254,889 | SCHEDULE 13G/A, 2025-08-14 |
| Nomura Holdings Inc | 0 | 15,708,085 | 0 | 15,708,085 | SCHEDULE 13G/A, 2025-11-14 |
| Nomura Global Financial Products Inc | 0 | 15,708,085 | 0 | 15,708,085 | SCHEDULE 13G/A, 2025-11-14 |
| Icahn Partners Master Fund LP | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2025-08-15 |
| Icahn Offshore LP | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2025-08-15 |
| Icahn Partners LP | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2025-08-15 |
| Icahn Onshore LP | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2025-08-15 |
| Icahn Capital LP | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2025-08-15 |
| Iph Gp LLC | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2025-08-15 |
| Icahn Enterprises Holdings L.P. | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2025-08-15 |
| Icahn Enterprises G.P. Inc. | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2025-08-15 |
| Beckton Corp. | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2025-08-15 |
| Carl C. Icahn | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2025-08-15 |
The latest filing names Bausch Health Companies Inc., with its principal executive office as 2150 St. Elzear Blvd. West, Laval (SCHEDULE 13G/A, 2025-11-14).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-14 | Paulson & Co. Inc. | 19.1% | SCHEDULE 13D/A |
| 2025-08-14 | Steven A. Tananbaum | 9.5% | SCHEDULE 13G/A |
| 2025-08-15 | Carl C. Icahn | 0% | SCHEDULE 13D/A |
| 2025-11-14 | Nomura Holdings Inc | 4.2% | SCHEDULE 13G/A |
Questions about who owns Bausch Health Companies Inc.
Who owns Bausch Health Companies Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Bausch Health Companies Inc.: Paulson & Co. Inc. (19.1%, Schedule 13D/A, filed 2025-08-14) and Steven A. Tananbaum (9.5%, Schedule 13G/A, filed 2025-08-14).
Who are the largest shareholders of Bausch Health Companies Inc.?
By the share each holder's latest filing reports, the largest holders of Bausch Health Companies Inc. on this page are Paulson & Co. Inc. (19.1%) and Steven A. Tananbaum (9.5%).
When did Paulson & Co. Inc. buy into Bausch Health Companies Inc.?
The filings give report dates, not purchase dates. The earliest filing from Paulson & Co. Inc. on this page is the Schedule 13D/A, filed 2025-08-14, reporting 19.1%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Bausch Health Companies Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.